Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H31NO10.ClH |
| Molecular Weight | 565.997 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]2C[C@@](O)(CC3=C(O)C4=C(C(=O)C5=C(OC)C=CC=C5C4=O)C(O)=C23)[C@H](C)O
InChI
InChIKey=LQLMJJJLWJUAMM-VSTLEVLBSA-N
InChI=1S/C27H31NO10.ClH/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33;/h4-6,10-11,14,16-17,22,29-30,32,34-35H,7-9,28H2,1-3H3;1H/t10-,11-,14-,16-,17-,22+,27-;/m0./s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cancer biomarker AKR1B10 and carbonyl metabolism. | 2009 Mar 16 |
|
| Daunorubicin metabolism in leukemic cells isolated from patients with acute myeloid leukemia. | 2010 Dec |
|
| AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group. | 2011 Aug 15 |
|
| Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase--Carbonyl reductase 1. | 2015 Jun 5 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
28008-53-9
Created by
admin on Sat Dec 16 19:50:13 GMT 2023 , Edited by admin on Sat Dec 16 19:50:13 GMT 2023
|
PRIMARY | |||
|
2JQ6974KH2
Created by
admin on Sat Dec 16 19:50:13 GMT 2023 , Edited by admin on Sat Dec 16 19:50:13 GMT 2023
|
PRIMARY | |||
|
168012705
Created by
admin on Sat Dec 16 19:50:13 GMT 2023 , Edited by admin on Sat Dec 16 19:50:13 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
